Rxivist logo

Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases

By Zheng Hu, Zan Li, Zhicheng Ma, Christina Curtis

Posted 31 Oct 2019
bioRxiv DOI: 10.1101/825240

Metastasis is the primary cause of cancer-related deaths, but the natural history, clonal evolution and impact of treatment are poorly understood. We analyzed exome sequencing data from 457 paired primary tumor and metastatic samples from 136 breast, colorectal and lung cancer patients, including untreated (n=99) and treated (n=100) metastatic tumors. Treated metastases often harbored private ‘driver’ mutations whereas untreated metastases did not, suggesting that treatment promotes clonal evolution. Polyclonal seeding was common in untreated lymph node metastases (n=17/29, 59%) and distant metastases (n=20/70, 29%), but less frequent in treated distant metastases (n=9/94, 10%). The low number of metastasis-private clonal mutations is consistent with early metastatic seeding, which we estimated commonly occurred 2-4 years prior to diagnosis across these cancers. Further, these data suggest that the natural course of metastasis is selectively relaxed relative to early tumor development and that metastasis-private mutations are not drivers of cancer spread but instead associated with drug resistance.

Download data

  • Downloaded 1,231 times
  • Download rankings, all-time:
    • Site-wide: 8,237 out of 89,756
    • In cancer biology: 223 out of 3,172
  • Year to date:
    • Site-wide: 2,499 out of 89,756
  • Since beginning of last month:
    • Site-wide: 7,697 out of 89,756

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)